Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
about
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategiesEstimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis.Systematic review of the economic value of diarrheal vaccinesCost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.Estimation of a preference-based carer experience scale.Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model.Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective.Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control studyImpact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS).Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis.A critical literature review of health economic evaluations of rotavirus vaccination.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples.Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression.Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014.Economics of vaccines revisited.Predicting carer health effects for use in economic evaluation.QALYs and carers.Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam.
P2860
Q22305437-9F5C3F5E-80DC-4718-8C3C-939B927F447FQ33474787-761AD78B-6103-4229-A0E6-A712635A954CQ33577996-2C5C10B3-CDA1-4FA2-931A-FFD0211AACB5Q33929557-BF255308-300A-42BD-BBC8-BD97C4E81A73Q34141946-AF29287F-B938-467E-B093-919335AE2861Q34201777-0D564952-BD1C-41D6-BC71-6435230345CEQ34675150-6C4B822F-26B1-4DEB-940C-104D7923658DQ35166897-26A76E19-4424-4805-B1BD-B8E5488521FDQ36149373-2DA7565B-F99F-4139-B181-02F514D201F1Q36294177-94E17B71-DE3E-4B3F-9F31-1B5238F2D2FFQ36650016-F56D4C1A-F9EC-4321-BAA0-AD3D25B65C5BQ36739996-D65AF440-C77D-48B5-9883-5E5B2505600CQ36914109-38C3523D-305B-4779-BA64-F20E8F476970Q37318562-3EF1A018-60E0-42F8-A761-41030D8E0BA0Q37417666-DEF5C1F3-B37F-43B7-AF8C-79AC86096789Q37514764-F207BEFE-783A-4E4D-B1C2-8B3108FC9AC7Q37866754-127D146C-5AF9-471D-818A-F9F6A22E56E3Q38105340-2A5D0797-634F-4891-8FF1-128B5304CEE9Q38546086-2D4FD04D-AE56-4723-B8F5-43B4F5E9AC28Q39600115-E7861F15-76A7-4C57-A7AE-DDF2EA5109E0Q41885924-6C23E06A-EF9A-4EDC-945B-8BF3519BBAD1Q41982214-AECD60EC-1B28-4DE3-A109-E40D950D959AQ45221185-EFADC907-BD8F-4AA2-B938-9834F9CF1BF7Q48188462-6B387DE1-A138-4774-B327-032140640469
P2860
Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cost-effectiveness of rotaviru ...... e'' disease impact in Belgium.
@en
type
label
Cost-effectiveness of rotaviru ...... e'' disease impact in Belgium.
@en
prefLabel
Cost-effectiveness of rotaviru ...... e'' disease impact in Belgium.
@en
P2860
P356
P1476
Cost-effectiveness of rotaviru ...... e'' disease impact in Belgium.
@en
P2093
Joke Bilcke
Philippe Beutels
P2860
P356
10.1177/0272989X08324955
P577
2008-10-23T00:00:00Z